These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker. Buckley PG; Alcock L; Heffernan J; Woods J; Brett F; Stallings RL; Farrell MA J Neuropathol Exp Neurol; 2011 Mar; 70(3):177-82. PubMed ID: 21293300 [TBL] [Abstract][Full Text] [Related]
5. Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma. Suh JH; Park CK; Park SH J Korean Med Sci; 2013 Apr; 28(4):593-601. PubMed ID: 23579442 [TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
7. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status. Durand K; Guillaudeau A; Pommepuy I; Mesturoux L; Chaunavel A; Gadeaud E; Porcheron M; Moreau JJ; Labrousse F J Clin Pathol; 2011 Sep; 64(9):793-801. PubMed ID: 21653654 [TBL] [Abstract][Full Text] [Related]
8. Alpha Internexin: A Surrogate Marker for 1p/19q Codeletion and Prognostic Marker in Anaplastic (WHO grade III) Gliomas. Rajmohan KS; Sugur HS; Shwetha SD; Pandey P; Arivazhagan A; Santosh V Neurol India; 2020; 68(4):832-837. PubMed ID: 32859823 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors. Chamberlain MC; Born D J Neurooncol; 2015 Nov; 125(2):249-51. PubMed ID: 26341371 [TBL] [Abstract][Full Text] [Related]
10. Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens. Gelpi E; Ambros IM; Birner P; Luegmayr A; Drlicek M; Fischer I; Kleinert R; Maier H; Huemer M; Gatterbauer B; Anton J; Rössler K; Budka H; Ambros PF; Hainfellner JA Mod Pathol; 2003 Jul; 16(7):708-15. PubMed ID: 12861068 [TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related]
12. Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic. Li YX; Shi Z; Aibaidula A; Chen H; Tang Q; Li KK; Chung NY; Chan DT; Poon WS; Mao Y; Wu J; Zhou L; Chan AK; Ng HK Oncotarget; 2016 Oct; 7(40):64615-64630. PubMed ID: 27556304 [TBL] [Abstract][Full Text] [Related]
13. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M; Berger H; Hartmann C; Schramm J; Westphal M; Simon M; Goldbrunner R; Krex D; Steinbach JP; Ostertag CB; Loeffler M; Pietsch T; von Deimling A; Clin Cancer Res; 2007 Dec; 13(23):6933-7. PubMed ID: 18056167 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender. Gresner SM; Rieske P; Wozniak K; Piaskowski S; Jaskolski DJ; Skowronski W; Golanska E; Sikorska B; Liberski PP Clin Neuropathol; 2006; 25(1):18-24. PubMed ID: 16465770 [TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
16. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K; Nishikawa R; Nakazato Y; Hirose T; Hirato J; Funada N; Fujimaki T; Hojo S; Kubo O; Ide T; Usui M; Ochiai C; Ito S; Takahashi H; Mukasa A; Asai A; Kirino T Clin Cancer Res; 2002 Jan; 8(1):196-201. PubMed ID: 11801559 [TBL] [Abstract][Full Text] [Related]
17. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors. Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553 [TBL] [Abstract][Full Text] [Related]
18. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas]. Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas. Xiong J; Liu Y; Wang Y; Ke RH; Mao Y; Ye ZR Chin Med J (Engl); 2010 Dec; 123(24):3566-73. PubMed ID: 22166632 [TBL] [Abstract][Full Text] [Related]
20. Coexpression of cyclin D1 and alpha-internexin in oligodendroglial tumors. Matsumura N; Nobusawa S; Ikota H; Hirato J; Hirose T; Yokoo H; Nakazato Y Brain Tumor Pathol; 2015 Oct; 32(4):261-7. PubMed ID: 26233522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]